explore -WSS

explore

author：hotspot 2025-09-30 20:34:51 - browse：88277

A syringe is prepared at a clinic in Norristown, Pa., Dec. 7, 2021. The Environmental Protection Agency finalized a rule Thursday, March 14, 2024, imposing stricter limits on a chemical used to sterilize medical equipment after finding a higher-than-expected cancer risk at facilities that use ethylene oxide to clean billions of devices including catheters and syringes. ( — The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. Matt Rourke/Ap

On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide that is used to sterilize most medical devices. Sterilizing facilities had polluted the air unchecked for decades, leading to disproportionately high cancer risks in surrounding communities.

The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. The rule will require commercial sterilization facilities to monitor and submit proof of their reduced emissions. It aligns with the Biden administration’s greater mission to end cancer and commitment to environmental justice, the EPA said.

Ethylene oxide is the most frequently used sterilizing chemical for devices that can’t be exposed to steam. It’s used to sanitize 20 billion devices in the U.S. per year, such as pacemakers, catheters, and ventilators. But long-term exposure to the gas can cause breast cancer, non-Hodgkin’s lymphoma, lymphocytic leukemia, and myeloma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Shifting the focus from loneliness to social health

entertainment

WSS

HIV drugs protect against transmission, even in unprotected sex

Life sciences investors close nearly $6 billion in new funds

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Cord blood banking comes at a high cost to babies

Ultragenyx gene therapy for rare liver ailment succeeds in late

All of Us, NIH's precision medicine initiative, gets a big boost

focus

explore

explore

Medicare proposal to cover medical devices draws a mixed reaction

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Apple is now the first public company to be valued at $3 trillion

The health care issue Democrats can’t solve: hospital reform

In Memoriam: Notable people who died in 2023

Bill would allow buprenorphine prescription for addiction via telehealth

FDA approval of Sarepta Duchenne genetic therapy gives me hope

NIH documents show early flaws of $1.6 billion long Covid program

State Dept. review finds Biden bears some blame for Afghanistan failures

The health care issue Democrats can’t solve: hospital reform

explore

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

How to convince healthy people to buy insurance

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

The health care issue Democrats can’t solve: hospital reform

What is microchimerism and how does it affect maternal health?

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

entertainment

leisure time

focus

explore